Found 152 matching trials
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease PHASE4 The Gardasil vaccine, a vaccine targeted towards the human papillomavirus (...
Show More Learn More & Join Trial
Long-term Immunogenicity of a HPV Vaccine in SLE N/A To study the 5-year immunogenicity against a quadrivalent HPV vaccine in pa...
Show More Location
Department of Medicine, Tuen Mun Hospital
Learn More & Join Trial
The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru PHASE1 This project will use a community based participatory research orientation ...
Show More Location
Centro de Salud Portada de Manchay
Learn More & Join Trial
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females PHASE3 This study is designed to evaluate the vaccine efficacy, immunogenicity and...
Show More Location
Liuzhou center for disease control and prevention
Learn More & Join Trial
Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023) PHASE3 This study will evaluate the efficacy, immunogenicity and safety of 9-valen...
Show More Status
Active Not Recruiting
Location
Lingchuan Center for Disease Control and Prevention ( Site 0002)
Learn More & Join Trial
Adolescent Vaccination in Pharmacies N/A The study aims to expand the evidence supporting pharmacy provision of adol...
Show More Learn More & Join Trial
Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED) PHASE3 This is an immunogenicity and safety study of Gardasil (V501) in females 9 ...
Show More Location
Multiple Locations
Learn More & Join Trial
Impact of HPV Vaccine On The Prevalence Of HPV In Norway N/A The overall aim of the study is to assess the effect of school-based Human ...
Show More Location
Oslo University Hospital, Cancer Registry of Norway
Learn More & Join Trial
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females PHASE3 The purpose of this study is to evaluate the immunogenicity and the safety ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Years PHASE3 Human papillomavirus (HPV) infection is the most common viral infection of ...
Show More Status
Active Not Recruiting
Location
Centre For Clinical Research, Kemri
Learn More & Join Trial